Retraction Note to: Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Tumor Biology

• Publication date

  2016-11-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-016-5481-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome.

  2012cited by this paper
• Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era

  2012cited by this paper
• Girdin maintains the stemness of glioblastoma stem cells

  2012cited by this paper
• ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma.

  2012cited by this paper
• Correlation of low SLC22A18 expression with poor prognosis in patients with glioma.

  2012cited by this paper
• Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma

  2011cited by this paper
• Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer

  2011cited by this paper
• Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression

  2011cited by this paper
• Expression and prognostic value of NDRG2 in human astrocytomas.

  2011cited by this paper
• Aldehyde Dehydrogenase 1 A1–Positive Cell Population Is Enriched in Tumor-Initiating Cells and Associated with Progression of Bladder Cancer

  2010cited by this paper
• Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase

  2010cited by this paper
• High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition

  2010cited by this paper
• Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients

  2009cited by this paper
• Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

  2009cited by this paper
• Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.

  2009cited by this paper
• High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

  2009cited by this paper
• NDRG4 Is Required for Cell Cycle Progression and Survival in Glioblastoma Cells*

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

  2009cited by this paper
• Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

  2009cited by this paper
• Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

  2009cited by this paper
• ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.

  2008cited by this paper
• Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma

  2008cited by this paper
• Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer

  2008cited by this paper
• Aldehyde dehydrogenase as a marker for stem cells.

  2008cited by this paper
• Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor.

  2008cited by this paper
• Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.

  2007cited by this paper
• Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma

  2007cited by this paper
• Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1.

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Glioma Therapy in Adults

  2006cited by this paper
• Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development

  2006cited by this paper
• Photodynamic therapy of high grade glioma - long term survival.

  2005cited by this paper
• NDRG2 expression and mutation in human liver and pancreatic cancers.

  2004cited by this paper
• N‐Myc downstream‐regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation

  2003cited by this paper
• Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism.

  2000cited by this paper
• MYC oncogenes and human neoplastic disease

  1999cited by this paper

• No citing papers are available for this paper.